8,655 Studies Reviewed. 86.9% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Whole Body / General

Effect of electromagnetic field on cyclic adenosine monophosphate (cAMP) in a human mu-opioid receptor cell model

Bioeffects Seen

Ross CL, Teli T, Harrison BS · 2016

Share:

A 5 Hz electromagnetic field inhibited pain-related cellular signaling 23% more effectively than morphine in human opioid receptor cells.

Plain English Summary

Summary written for general audiences

Researchers at Wake Forest exposed human opioid receptor cells to 5 Hz electromagnetic fields and compared the results to morphine treatment. The EMF exposure reduced cellular signaling activity (cAMP) by 23% more than morphine, while 13 Hz EMF had no effect. This suggests specific EMF frequencies might offer pain relief without opioid side effects.

Why This Matters

This study reveals something remarkable: a specific EMF frequency (5 Hz) influenced human opioid receptor cells more effectively than morphine itself. The science demonstrates that electromagnetic fields don't just create generic biological effects. They produce frequency-specific responses, which is exactly what we see here. The 13 Hz frequency produced no meaningful change, while 5 Hz significantly altered cellular signaling pathways involved in pain perception.

What this means for you: the same biological systems that respond to pharmaceutical pain medication can be influenced by specific electromagnetic frequencies. The researchers aren't proposing EMF as a pain treatment (this was a cell study, not a clinical trial), but they're identifying biological mechanisms that deserve serious attention. The frequency specificity matters because it challenges the oversimplified narrative that all EMF effects are either universally harmful or universally benign. Your body's cellular machinery responds differently to different frequencies, which is why blanket statements about EMF safety or danger often miss the complexity of what's actually happening at the biological level.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Ross CL, Teli T, Harrison BS (2016). Effect of electromagnetic field on cyclic adenosine monophosphate (cAMP) in a human mu-opioid receptor cell model.
Show BibTeX
@article{ross_cl_teli_t_harrison_bs_ce4526,
  author = {Ross CL and Teli T and Harrison BS},
  title = {Effect of electromagnetic field on cyclic adenosine monophosphate (cAMP) in a human mu-opioid receptor cell model},
  year = {2016},
  doi = {10.3109/15368378.2015.1043556},
  
}
DOI: 10.3109/15368378.2015.1043556PubMed: 26151161

Quick Questions About This Study

The 5 Hz electromagnetic field reduced cAMP activity in human opioid receptor cells by 23% more than morphine treatment. This suggests the specific frequency produced a stronger effect on the cellular signaling pathway involved in pain perception than the pharmaceutical opioid.
The 13 Hz frequency produced results similar to controls (no significant effect), while 5 Hz significantly inhibited cAMP. This demonstrates frequency-specific biological responses. Different frequencies interact with cellular systems differently, much like different radio stations operate on different channels. Biology responds selectively to specific electromagnetic frequencies.
Cyclic adenosine monophosphate (cAMP) is a cellular messenger involved in pain signaling through opioid receptors. When cAMP activity decreases, pain signals are reduced. Both morphine and the 5 Hz EMF in this study lowered cAMP levels, which is associated with pain relief in biological systems.
Researchers used Chinese Hamster Ovary (CHO) cells that were genetically modified to express human mu-opioid receptors. These are the same receptors that morphine and other opioid medications bind to in the human body. This allowed controlled testing of EMF effects on human pain pathways.
This was a laboratory cell study, not a clinical trial in humans. While results suggest 5 Hz EMF could influence pain pathways without opioid side effects, extensive human testing would be needed before any clinical applications. The study identifies a biological mechanism worthy of further investigation.